Pulse Biosciences (PLSE) Deferred Taxes (2015)

Pulse Biosciences (PLSE) posted quarterly Deferred Taxes of -$518000.0 for Q4 2015, down 7.25% quarter-over-quarter from -$483000.0 in Q3 2015.

Pulse Biosciences (PLSE) Deferred Taxes (2015) Analysis & Trends

Pulse Biosciences' Deferred Taxes history runs 1 years deep, the most recent figure standing at -$518000.0 for Q4 2015.

In Q4 2015, Deferred Taxes changed N/A year-over-year to -$518000.0; the TTM figure through Dec 2015 stood at -$1.7 million (changed N/A YoY), while the FY2015 annual figure was -$1.7 million, down 7104.35% from the prior year.
Deferred Taxes for Q4 2015 stood at -$518000.0, down from -$483000.0 in the prior quarter.
The five-year high for Deferred Taxes was -$299000.0 in Q1 2015, with the low at -$518000.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	-31.00 Mn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	-74.00 Mn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	-
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	-
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	64.00 Mn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	-
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	-47.00 Mn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	43.50 Mn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	-34.00 Mn
10	Pulse Biosciences	3.50 Bn	3.50 Bn	161,000.00	-

Download Data